These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 15864268)

  • 61. MicroRNA-based targeting of the Rho/ROCK pathway in therapeutic strategies after spinal cord injury.
    Kimura T; Horikoshi Y
    Neural Regen Res; 2023 Feb; 18(2):311-312. PubMed ID: 35900410
    [No Abstract]   [Full Text] [Related]  

  • 62. A Piece of the ROCK: A Critical Role for Rho Kinases in the Nervous System.
    Maiese K
    Curr Neurovasc Res; 2018; 15(4):275. PubMed ID: 30466383
    [No Abstract]   [Full Text] [Related]  

  • 63. Rho kinases (ROCKs) in sepsis-induced acute lung injury.
    Narain R
    J Thorac Dis; 2012 Feb; 4(1):12-4. PubMed ID: 22295160
    [No Abstract]   [Full Text] [Related]  

  • 64. VERTEBRATE REMAINS FROM CENOZOIC ROCKS.
    Needham CE
    Science; 1936 Dec; 84(2189):537. PubMed ID: 17806559
    [No Abstract]   [Full Text] [Related]  

  • 65. Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity.
    Amano M; Nakayama M; Kaibuchi K
    Cytoskeleton (Hoboken); 2010 Sep; 67(9):545-54. PubMed ID: 20803696
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The structure of dimeric ROCK I reveals the mechanism for ligand selectivity.
    Jacobs M; Hayakawa K; Swenson L; Bellon S; Fleming M; Taslimi P; Doran J
    J Biol Chem; 2006 Jan; 281(1):260-8. PubMed ID: 16249185
    [TBL] [Abstract][Full Text] [Related]  

  • 67. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice.
    Nakagawa O; Fujisawa K; Ishizaki T; Saito Y; Nakao K; Narumiya S
    FEBS Lett; 1996 Aug; 392(2):189-93. PubMed ID: 8772201
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Axon growth inhibition by RhoA/ROCK in the central nervous system.
    Fujita Y; Yamashita T
    Front Neurosci; 2014; 8():338. PubMed ID: 25374504
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacologic inhibition of ROCK2 suppresses amyloid-β production in an Alzheimer's disease mouse model.
    Herskowitz JH; Feng Y; Mattheyses AL; Hales CM; Higginbotham LA; Duong DM; Montine TJ; Troncoso JC; Thambisetty M; Seyfried NT; Levey AI; Lah JJ
    J Neurosci; 2013 Dec; 33(49):19086-98. PubMed ID: 24305806
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease.
    Tönges L; Frank T; Tatenhorst L; Saal KA; Koch JC; Szego ÉM; Bähr M; Weishaupt JH; Lingor P
    Brain; 2012 Nov; 135(Pt 11):3355-70. PubMed ID: 23087045
    [TBL] [Abstract][Full Text] [Related]  

  • 71. ROCK inhibition in models of neurodegeneration and its potential for clinical translation.
    Koch JC; Tatenhorst L; Roser AE; Saal KA; Tönges L; Lingor P
    Pharmacol Ther; 2018 Sep; 189():1-21. PubMed ID: 29621594
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rho-kinase ROCK inhibitors reduce oligomeric tau protein.
    Hamano T; Shirafuji N; Yen SH; Yoshida H; Kanaan NM; Hayashi K; Ikawa M; Yamamura O; Fujita Y; Kuriyama M; Nakamoto Y
    Neurobiol Aging; 2020 May; 89():41-54. PubMed ID: 31982202
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders?
    Chen M; Liu A; Ouyang Y; Huang Y; Chao X; Pi R
    Expert Opin Investig Drugs; 2013 Apr; 22(4):537-50. PubMed ID: 23461757
    [TBL] [Abstract][Full Text] [Related]  

  • 74. ROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS.
    Koch JC; Tönges L; Barski E; Michel U; Bähr M; Lingor P
    Cell Death Dis; 2014 May; 5(5):e1225. PubMed ID: 24832597
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential.
    Feng Y; LoGrasso PV; Defert O; Li R
    J Med Chem; 2016 Mar; 59(6):2269-300. PubMed ID: 26486225
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of RhoA/ROCK signaling in Alzheimer's disease.
    Cai R; Wang Y; Huang Z; Zou Q; Pu Y; Yu C; Cai Z
    Behav Brain Res; 2021 Sep; 414():113481. PubMed ID: 34302876
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacokinetic and safety profile of PT109B, a novel multi-targeted compound against Alzheimer's disease.
    Wu Y; Yang Y; Liu J; Li Y; Pi R; Ren Y; Jiang T; Wang Y; Zhong G
    Eur J Pharm Sci; 2023 Sep; 188():106532. PubMed ID: 37479046
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of polyethylene glycol 400 on the pharmacokinetics and tissue distribution of baicalin by intravenous injection based on the enzyme activity of UGT1A8/1A9.
    Shang LY; Zhou MH; Cao SY; Zhang M; Wang PJ; Zhang S; Meng XX; Yang QM; Gao XL
    Eur J Pharm Sci; 2023 Jan; 180():106328. PubMed ID: 36379359
    [TBL] [Abstract][Full Text] [Related]  

  • 79. ROCK and PDE-5 Inhibitors for the Treatment of Dementia: Literature Review and Meta-Analysis.
    Lee DH; Lee JY; Hong DY; Lee EC; Park SW; Jo YN; Park YJ; Cho JY; Cho YJ; Chae SH; Lee MR; Oh JS
    Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740369
    [TBL] [Abstract][Full Text] [Related]  

  • 80. RhoA Signaling in Neurodegenerative Diseases.
    Schmidt SI; Blaabjerg M; Freude K; Meyer M
    Cells; 2022 May; 11(9):. PubMed ID: 35563826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.